Richter-Schrag Hans-Jürgen, Glatz Torben, Walker Christine, Fischer Andreas, Thimme Robert
Hans-Jürgen Richter-Schrag, Christine Walker, Andreas Fischer, Robert Thimme, Center of Interdisciplinary Gastrointestinal Endoscopy, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, D-79106 Freiburg, Germany.
World J Gastroenterol. 2016 Nov 7;22(41):9162-9171. doi: 10.3748/wjg.v22.i41.9162.
To evaluate rebleeding, primary failure (PF) and mortality of patients in whom over-the-scope clips (OTSCs) were used as first-line and second-line endoscopic treatment (FLET, SLET) of upper and lower gastrointestinal bleeding (UGIB, LGIB).
A retrospective analysis of a prospectively collected database identified all patients with UGIB and LGIB in a tertiary endoscopic referral center of the University of Freiburg, Germany, from 04-2012 to 05-2016 ( = 93) who underwent FLET and SLET with OTSCs. The complete Rockall risk scores were calculated from patients with UGIB. The scores were categorized as < or ≥ 7 and were compared with the original Rockall data. Differences between FLET and SLET were calculated. Univariate and multivariate analysis were performed to evaluate the factors that influenced rebleeding after OTSC placement.
Primary hemostasis and clinical success of bleeding lesions (without rebleeding) was achieved in 88/100 (88%) and 78/100 (78%), respectively. PF was significantly lower when OTSCs were applied as FLET compared to SLET (4.9% 23%, = 0.008). In multivariate analysis, patients who had OTSC placement as SLET had a significantly higher rebleeding risk compared to those who had FLET (OR 5.3; = 0.008). Patients with Rockall risk scores ≥ 7 had a significantly higher in-hospital mortality compared to those with scores < 7 (35% 10%, = 0.034). No significant differences were observed in patients with scores < or ≥ 7 in rebleeding and rebleeding-associated mortality.
Our data show for the first time that FLET with OTSC might be the best predictor to successfully prevent rebleeding of gastrointestinal bleeding compared to SLET. The type of treatment determines the success of primary hemostasis or primary failure.
评估使用套扎式内镜夹(OTSCs)作为上、下消化道出血(UGIB、LGIB)一线和二线内镜治疗(FLET、SLET)的患者的再出血、原发性止血失败(PF)及死亡率。
对前瞻性收集的数据库进行回顾性分析,确定了2012年4月至2016年5月期间在德国弗莱堡大学三级内镜转诊中心接受OTSCs FLET和SLET治疗的所有UGIB和LGIB患者(n = 93)。计算UGIB患者的完整Rockall风险评分。将评分分为<7或≥7,并与原始Rockall数据进行比较。计算FLET和SLET之间的差异。进行单因素和多因素分析以评估影响OTSC放置后再出血的因素。
分别有88/100(88%)和78/100(78%)的出血病变实现了原发性止血和临床成功(无再出血)。与SLET相比,OTSCs作为FLET应用时PF显著更低(4.9%对23%,P = 0.008)。在多因素分析中,与接受FLET的患者相比,接受SLET的OTSC放置患者再出血风险显著更高(OR 5.3;P = 0.008)。Rockall风险评分≥7的患者与评分<7的患者相比,住院死亡率显著更高(35%对10%,P = 0.034)。评分<7或≥7的患者在再出血及再出血相关死亡率方面未观察到显著差异。
我们的数据首次表明,与SLET相比,OTSC FLET可能是成功预防胃肠道出血再出血的最佳预测指标。治疗类型决定原发性止血或原发性止血失败的成功与否。